Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mollard, R. C.
Right arrow Articles by Weiler, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollard, R. C.
Right arrow Articles by Weiler, H. A.
© 2005 The American Society for Nutritional Sciences J. Nutr. 135:499-504, March 2005


Nutrient Metabolism

(n-3) Fatty Acids Reduce the Release of Prostaglandin E2 from Bone but Do Not Affect Bone Mass in Obese (fa/fa) and Lean Zucker Rats1,2

Rebecca C. Mollard, Melani E. Gillam, Trisha M. Wood, Carla G. Taylor and Hope A. Weiler3

Department of Human Nutritional Sciences, University of Manitoba, Winnipeg, MB, R3T 2N2 Canada

3To whom correspondence should be addressed. E-mail: hweiler{at}cc.umanitoba.ca.

Childhood obesity is prevalent and linked to the development of Type 2 diabetes mellitus (DM) and poor bone health. Some PUFA enhance bone mass and thus may improve bone health in obese children. The study objective was to determine the effects of dietary (n-6) compared with (n-3) essential PUFA and long-chain PUFA (LCPUFA) on bone in an obese and insulin-resistant state. Male fa/fa (n = 48) and lean Zucker rats (n = 48) were fed diets containing safflower oil [SO, high (n-6) PUFA], flaxseed oil [FXO, high (n-3) PUFA], or menhaden oil [MO, high (n-3) LCPUFA] for 9 wk. Measurements included the following: femur bone area (BA), mineral content (BMC), density (BMD), morphometry and ex vivo release of prostaglandin E2 (PGE2); plasma osteocalcin and C-terminal telopeptides of type I collagen. Differences among groups were detected using 2-way ANOVA. Genotype effects in the fa/fa rats included lower femoral weight, length, BA, and BMC, as well as femoral head and proximal epiphysis widths compared with the lean rats, but BMD was not affected. Femur BA, BMC, and BMD did not differ among the dietary groups, but diaphysis width was elevated in the MO group and PGE2 release was reduced by the FXO and MO diets. No genotype x diet interactions were observed. These data indicate that the fa/fa Zucker rat is at risk for low bone mass and that dietary (n-3) FA effectively reduce PGE2 release. Whether reduced PGE2 will support optimal peak bone mass during childhood and conserve bone mass with aging warrants investigation.


KEY WORDS: • bone • obesity • hyperinsulinemia • Type 2 diabetes mellitus • PUFA




This article has been cited by other articles:


Home page
Poult. Sci.Home page
H. T. Baird, D. L. Eggett, and S. Fullmer
Varying Ratios of Omega-6:Omega-3 Fatty Acids on the Pre-and Postmortem Bone Mineral Density, Bone Ash, and Bone Breaking Strength of Laying Chickens
Poult. Sci., February 1, 2008; 87(2): 323 - 328.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
L. L. Burr, C. G. Taylor, and H. A. Weiler
Dietary Conjugated Linoleic Acid Does Not Adversely Affect Bone Mass in Obese fa/fa or Lean Zucker Rats.
Experimental Biology and Medicine, November 1, 2006; 231(10): 1602 - 1609.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition